Overview

The Effects of ADHD Medication (TEAM) Study

Status:
Completed
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
This study evaluates the effects of receiving and then discontinuing methylphenidate (MPH) in children with ADHD. After receiving MPH for 8 weeks, participants will be randomized to either discontinue MPH (and receive placebo) OR remain on MPH for 4 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborator:
Seattle Children's Hospital
Treatments:
Methylphenidate